$BUJA
Bukit Jalil Global Acquisition 1 Ltd.

2023 Q4 Form 10-Q Financial Statement

#000192998023000269 Filed on November 13, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2023 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $0.00 $0.00 $130.0K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $82.02K $255.2K $130.0K
YoY Change
Operating Profit -$255.2K -$129.4K
YoY Change 1601.05%
Interest Expense $786.8K $738.2K $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $1.540M
YoY Change
Pretax Income $704.8K $483.0K -$130.0K
YoY Change
Income Tax
% Of Pretax Income
Net Earnings $704.8K $483.0K -$129.3K
YoY Change -3320.07%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.09 $0.06 -$0.09
COMMON SHARES
Basic Shares Outstanding 7.762M shares 7.762M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q4 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $295.4K $355.1K $680.0K
YoY Change
Cash & Equivalents $295.4K $355.1K $681.6K
Short-Term Investments
Other Short-Term Assets $101.7K $127.5K $120.0K
YoY Change
Inventory
Prepaid Expenses $101.7K $127.5K
Receivables
Other Receivables $0.00 $0.00
Total Short-Term Assets $397.1K $482.6K $800.0K
YoY Change 24.09%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $59.88M $59.10M $58.36M
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $59.88M $59.10M $58.36M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $397.1K $482.6K $800.0K
Total Long-Term Assets $59.88M $59.10M $58.36M
Total Assets $60.28M $59.58M $59.16M
YoY Change 18738.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $118.9K $146.4K $140.0K
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $157.6K $161.8K $150.0K
YoY Change -49.73%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.150M $1.150M $1.150M
YoY Change
Total Long-Term Liabilities $1.150M $1.150M $1.150M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $157.6K $161.8K $150.0K
Total Long-Term Liabilities $1.150M $1.150M $1.150M
Total Liabilities $1.308M $1.312M $1.300M
YoY Change 317.12%
SHAREHOLDERS EQUITY
Retained Earnings $0.00 $0.00 -$147.5K
YoY Change -100.0%
Common Stock $202.00 $202.00 $202.00
YoY Change 40.28%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $58.97M $7.046M $9.747M
YoY Change
Total Liabilities & Shareholders Equity $60.28M $59.58M $59.16M
YoY Change 18738.97%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $704.8K $483.0K -$129.3K
YoY Change -3320.07%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $69.99K -$321.6K -$180.0K
YoY Change 2044.27%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 -$2.500K -$58.36M
YoY Change
Cash From Investing Activities $0.00 -$2.500K -$58.36M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -129.7K -750.0 59.13M
YoY Change -105.0%
NET CHANGE
Cash From Operating Activities 69.99K -321.6K -180.0K
Cash From Investing Activities 0.000 -2.500K -58.36M
Cash From Financing Activities -129.7K -750.0 59.13M
Net Change In Cash -59.74K -324.9K 590.0K
YoY Change
FREE CASH FLOW
Cash From Operating Activities $69.99K -$321.6K -$180.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Cash
Cash
0 usd
CY2022Q4 bukit Deferred Underwriters Discountnoncurrent
DeferredUnderwritersDiscountnoncurrent
0 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-15000 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
3089 usd
CY2022Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
0 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
483010 usd
us-gaap Net Income Loss
NetIncomeLoss
354026 usd
CY2023Q3 bukit Weighted Average Ordinary Shares Outstanding Basic And Diluted
WeightedAverageOrdinarySharesOutstandingBasicAndDiluted
5750000 shares
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
dei Entity Central Index Key
EntityCentralIndexKey
0001956055
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
490000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1437500 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2011807 shares
CY2022Q4 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
1437500 shares
CY2023Q3 bukit Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
212153 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41729
dei Entity Registrant Name
EntityRegistrantName
BUKIT JALIL GLOBAL ACQUISITION 1 LTD.
dei Entity Address Address Line1
EntityAddressAddressLine1
31-1 Taman Miharja Phase 3B
dei Entity Address Address Line2
EntityAddressAddressLine2
Jalan 3/93
dei Entity Address Address Line3
EntityAddressAddressLine3
2 ½ Miles, Cheras
dei Entity Address City Or Town
EntityAddressCityOrTown
Kuala Lumpur
dei Entity Address Country
EntityAddressCountry
MY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55200
dei City Area Code
CityAreaCode
603
dei Local Phone Number
LocalPhoneNumber
91339688
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7761807 shares
CY2023Q3 us-gaap Cash
Cash
355108 usd
CY2023Q3 bukit Deferred Underwriters Discountnoncurrent
DeferredUnderwritersDiscountnoncurrent
1150000 usd
CY2023Q3 us-gaap Temporary Equity Share Subscriptions
TemporaryEquityShareSubscriptions
5750000 shares
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
490000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2011807 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1437500 shares
CY2022Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
15000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
125350 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-255158 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-384646 usd
CY2023Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
2585 usd
CY2023Q3 us-gaap Investment Income Dividend
InvestmentIncomeDividend
735583 usd
us-gaap Investment Income Dividend
InvestmentIncomeDividend
735583 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-15000 usd
bukit Weighted Average Ordinary Shares Outstanding Basic And Diluted
WeightedAverageOrdinarySharesOutstandingBasicAndDiluted
1958791 shares
CY2023Q3 bukit Earning Per Ordinary Shares Basic And Diluted
EarningPerOrdinarySharesBasicAndDiluted
0.20
bukit Earning Per Ordinary Shares Basic And Diluted
EarningPerOrdinarySharesBasicAndDiluted
0.82
CY2023Q3 bukit Weighted Average Number Of Ordinary Shares Outstanding Basic And Diluted
WeightedAverageNumberOfOrdinarySharesOutstandingBasicAndDiluted
2018049 shares
bukit Weighted Average Number Of Ordinary Shares Outstanding Basic And Diluted
WeightedAverageNumberOfOrdinarySharesOutstandingBasicAndDiluted
1633143 shares
CY2022Q3 bukit Weighted Average Number Of Ordinary Shares Outstanding Basic And Diluted
WeightedAverageNumberOfOrdinarySharesOutstandingBasicAndDiluted
1250000 shares
CY2023Q3 us-gaap Net Income Loss Per Outstanding Limited Partnership And General Partnership Unit Basic And Diluted
NetIncomeLossPerOutstandingLimitedPartnershipAndGeneralPartnershipUnitBasicAndDiluted
-0.34
us-gaap Net Income Loss Per Outstanding Limited Partnership And General Partnership Unit Basic And Diluted
NetIncomeLossPerOutstandingLimitedPartnershipAndGeneralPartnershipUnitBasicAndDiluted
-0.77
CY2022Q3 us-gaap Net Income Loss Per Outstanding Limited Partnership And General Partnership Unit Basic And Diluted
NetIncomeLossPerOutstandingLimitedPartnershipAndGeneralPartnershipUnitBasicAndDiluted
-0.01
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
6496 usd
bukit Sale Of Public Units Through Public Offering Amount
SaleOfPublicUnitsThroughPublicOfferingAmount
57500000 usd
bukit Sale Of Private Placement Shares Amount
SaleOfPrivatePlacementSharesAmount
4243070 usd
bukit Issuance Of Representative Shares Amount
IssuanceOfRepresentativeSharesAmount
817500 usd
us-gaap Share Based Compensation
ShareBasedCompensation
125350 usd
bukit Underwriters Discount
UnderwritersDiscount
-3162500 usd
us-gaap Other Expenses
OtherExpenses
1540024 usd
bukit Reclassification Of Ordinary Shares Subject To Redemption Amount
ReclassificationOfOrdinarySharesSubjectToRedemptionAmount
-52350300 usd
bukit Allocation Of Offering Costs To Ordinary Shares Subject To Redemption
AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption
4236160 usd
us-gaap Net Income Loss
NetIncomeLoss
-128984 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
9746768 usd
CY2023Q3 bukit Accretion Of Initial Measurement Of Ordinary Share Subject To Redemption Value
AccretionOfInitialMeasurementOfOrdinaryShareSubjectToRedemptionValue
-2372978 usd
CY2023Q3 bukit Accretion Of Subsequent Measurement Of Ordinary Share Subject To Redemption Value
AccretionOfSubsequentMeasurementOfOrdinaryShareSubjectToRedemptionValue
-735583 usd
CY2023Q3 bukit Offering Cost
OfferingCost
-75000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
483010 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
7046217 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
0 usd
CY2022Q3 bukit Founder Shares Issued To Initial Shareholders Amount
FounderSharesIssuedToInitialShareholdersAmount
50000 usd
CY2022Q3 bukit Founder Shares Issued To Initial Shareholder Amount
FounderSharesIssuedToInitialShareholderAmount
25000 usd
CY2022Q3 bukit Founder Shares Surrendered Amount
FounderSharesSurrenderedAmount
-50000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-15000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-10000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-15000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
125350 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
bukit Dividend Income On Investments Held In Trust
DividendIncomeOnInvestmentsHeldInTrust
-735583 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
70278 usd
CY2022Q3 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
0 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-127525 usd
CY2022Q3 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
0 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-118185 usd
CY2022Q3 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
0 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-431639 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15000 usd
bukit Payments To Acquire Assets Held For Trust Account
PaymentsToAcquireAssetsHeldForTrustAccount
58362500 usd
CY2022Q3 bukit Payments To Acquire Assets Held For Trust Account
PaymentsToAcquireAssetsHeldForTrustAccount
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-58362500 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2022Q3 us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
25000 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 usd
CY2022Q3 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
10000 usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
55487500 usd
CY2022Q3 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0 usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
4243070 usd
CY2022Q3 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0 usd
us-gaap Proceeds From Issuance Of Medium Term Notes
ProceedsFromIssuanceOfMediumTermNotes
168135 usd
CY2022Q3 us-gaap Proceeds From Issuance Of Medium Term Notes
ProceedsFromIssuanceOfMediumTermNotes
0 usd
us-gaap Repayments Of Medium Term Notes
RepaymentsOfMediumTermNotes
433508 usd
CY2022Q3 us-gaap Repayments Of Medium Term Notes
RepaymentsOfMediumTermNotes
0 usd
us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
15438 usd
CY2022Q3 us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
0 usd
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
331388 usd
CY2022Q3 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
59149247 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
355108 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
355108 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
bukit Deferred Offering Costs Included In Accrued Expenses
DeferredOfferingCostsIncludedInAccruedExpenses
209285 usd
CY2022Q3 bukit Deferred Offering Costs Included In Accrued Expenses
DeferredOfferingCostsIncludedInAccruedExpenses
0 usd
us-gaap Deferred Purchased Power Costs
DeferredPurchasedPowerCosts
7147 usd
CY2022Q3 us-gaap Deferred Purchased Power Costs
DeferredPurchasedPowerCosts
0 usd
bukit Deferred Underwriters Discount
DeferredUnderwritersDiscount
1150000 usd
CY2022Q3 bukit Deferred Underwriters Discount
DeferredUnderwritersDiscount
0 usd
bukit Issuance Of Representative Shares
IssuanceOfRepresentativeShares
817500 usd
CY2022Q3 bukit Issuance Of Representative Shares
IssuanceOfRepresentativeShares
0 usd
bukit Allocation Of Offering Costs To Ordinary Shares Subject To Redemption
AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption
4236160 usd
CY2022Q3 bukit Allocation Of Offering Costs To Ordinary Shares Subject To Redemption
AllocationOfOfferingCostsToOrdinarySharesSubjectToRedemption
0 usd
bukit Accretion Of Initial Measurement Of Ordinary Shares Subject To Redemption Value
AccretionOfInitialMeasurementOfOrdinarySharesSubjectToRedemptionValue
2372978 usd
CY2022Q3 bukit Accretion Of Initial Measurement Of Ordinary Shares Subject To Redemption Value
AccretionOfInitialMeasurementOfOrdinarySharesSubjectToRedemptionValue
0 usd
bukit Accretion Of Subsequent Measurement Of Ordinary Shares Subject To Redemption Value
AccretionOfSubsequentMeasurementOfOrdinarySharesSubjectToRedemptionValue
735583 usd
CY2022Q3 bukit Accretion Of Subsequent Measurement Of Ordinary Shares Subject To Redemption Value
AccretionOfSubsequentMeasurementOfOrdinarySharesSubjectToRedemptionValue
0 usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
4243070 usd
us-gaap Gross Transaction Volume
GrossTransactionVolume
4702524 usd
us-gaap Investment Banking Advisory Brokerage And Underwriting Fees And Commissions
InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions
2012500 usd
us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
1150000 usd
CY2023Q3 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.50 pure
CY2023Q3 us-gaap Cash
Cash
355108 usd
CY2023Q3 bukit Working Capital Deficit
WorkingCapitalDeficit
320835 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p>
CY2023Q3 us-gaap Cash
Cash
355108 usd
CY2022Q4 us-gaap Cash
Cash
0 usd
CY2023Q3 us-gaap Stock Redeemed Or Called During Period Shares
StockRedeemedOrCalledDuringPeriodShares
735583 shares
us-gaap Stock Redeemed Or Called During Period Shares
StockRedeemedOrCalledDuringPeriodShares
735583 shares
CY2023Q3 us-gaap Assets Held In Trust
AssetsHeldInTrust
59098083 usd
CY2023Q3 us-gaap Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
2372978 usd
CY2023Q3 us-gaap Accretion Expense
AccretionExpense
7875392 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
125350 usd
us-gaap Other Restructuring Costs
OtherRestructuringCosts
4702524 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. As of September 30, 2023 and December 31, 2022, $105,108 and $0 respectively, was over the Federal Deposit Insurance Corporation (FDIC) limit.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Furthermore, recent bank failures, non-performance, or other adverse developments that affect financial institutions could impair the ability of one or more of the banks participating in the credit facility from honoring their commitments. Such events could have a material adverse effect on the Company’s financial condition or results of operations.</p>
CY2023Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2023Q3 bukit Exceeds Cash Insured Limit
ExceedsCashInsuredLimit
105108 usd
CY2022Q4 bukit Exceeds Cash Insured Limit
ExceedsCashInsuredLimit
0 usd
CY2023Q3 us-gaap Assets Held In Trust
AssetsHeldInTrust
59098083 usd
CY2022Q4 us-gaap Assets Held In Trust
AssetsHeldInTrust
0 usd
bukit Purchase Of Aggregate Shares
PurchaseOfAggregateShares
5750000 shares
CY2023Q3 us-gaap Profit Loss
ProfitLoss
483010 usd
us-gaap Profit Loss
ProfitLoss
354026 usd
CY2023Q3 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
-3108261 usd
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
-3108561 usd
CY2023Q3 bukit Net Loss Includingaccretionofcarryingvalueofredemptionvalue
NetLossIncludingaccretionofcarryingvalueofredemptionvalue
-2625551 usd
bukit Net Loss Includingaccretionofcarryingvalueofredemptionvalue
NetLossIncludingaccretionofcarryingvalueofredemptionvalue
-2754535 usd
bukit Stock Issued During Period Shares Acquisitionss
StockIssuedDuringPeriodSharesAcquisitionss
750000 shares
CY2023Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
CY2023Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10
bukit Gross Proceeds Amount
GrossProceedsAmount
57500000 usd
us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
57500000 usd
bukit Proceeds From Ordinary Shares Allocated To Public Rights And Warrants
ProceedsFromOrdinarySharesAllocatedToPublicRightsAndWarrants
-5149700 usd
bukit Proceeds From Shares Allocated Towards Offering Costs Of Public Shares
ProceedsFromSharesAllocatedTowardsOfferingCostsOfPublicShares
-4236160 usd
us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
3108561 usd
bukit Redemption Of Ordinary Share Amount
RedemptionOfOrdinaryShareAmount
51222701 usd
us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
424307 shares
CY2023Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
4243070 usd
bukit Description Registration Rights
DescriptionRegistrationRights
the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up period, which occurs (1) in the case of the insider shares, (i) with respect to 50% of the insider shares, until the earlier to occur of six months after the date of the consummation of the Company’s initial Business Combination and the date on which the closing price of ordinary shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing after the Company’s initial Business Combination and (2) with respect to the remaining 50% of the insider shares, six months after the date of the consummation of the Company’s initial Business Combination, or earlier, in either case, if, subsequent to the Company’s initial Business Combination, the Company consummates a liquidation, merger, share exchange or other similar transaction which results in all of its shareholders having the right to exchange their shares for cash, securities or other property, and (2) in the case of the Private Placement Units and the securities underlying such units, until the completion of the Company’s initial Business Combination
bukit Gross Proceeds Discount Discount
GrossProceedsDiscountDiscount
0.035 pure
bukit Gross Proceeds Discount Of Initial Public Offering
GrossProceedsDiscountOfInitialPublicOffering
2012500 usd
bukit Cash Fee Of The Gross Proceeds Percentage
CashFeeOfTheGrossProceedsPercentage
0.02 pure
bukit Pay Gross Proceeds Of The Ipo
PayGrossProceedsOfTheIpo
1150000 usd
CY2023Q3 bukit Deferred Discount Credit
DeferredDiscountCredit
1150000 usd
bukit Issurance Of Representative Shares Upon The Consummation Of The Ipo
IssuranceOfRepresentativeSharesUponTheConsummationOfTheIpo
150000 shares
bukit Description Of Representative Shares
DescriptionOfRepresentativeShares
The Representative Shares have been deemed compensation by FINRA and are therefore subject to a lock-up for a period of 180 days immediately following the date of the commencement of sales of the IPO pursuant to FINRA Rule 5110(e)(1)
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
150000 usd
bukit Representative Issuranceofrepresentativesharesupontheconsummationoftheip
RepresentativeIssuranceofrepresentativesharesupontheconsummationoftheip
817500 shares
us-gaap Warrant Exercise Price Increase
WarrantExercisePriceIncrease
5.45
CY2023Q3 us-gaap Capital Units Authorized
CapitalUnitsAuthorized
500000000 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
490000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
2011807 shares
us-gaap Common Stock Voting Rights
CommonStockVotingRights
one vote
CY2023Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
CY2023Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
212153 shares
CY2023Q3 bukit Class Of Warrant Or Right Price
ClassOfWarrantOrRightPrice
0.01
bukit Trading Periodgranted
TradingPeriodgranted
P30D
bukit Description Of Warrant
DescriptionOfWarrant
if, and only if, the closing price of the ordinary shares equals or exceeds $16.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “-Warrants-Public Shareholders’ Warrants-Anti-dilution Adjustments”) for any 20 trading days within a 30-trading day period ending three business days before the Company sends the notice of redemption to the warrant holders)

Files In Submission

Name View Source Status
0001929980-23-000269-index-headers.html Edgar Link pending
0001929980-23-000269-index.html Edgar Link pending
0001929980-23-000269.txt Edgar Link pending
0001929980-23-000269-xbrl.zip Edgar Link pending
bukit-20230930.xsd Edgar Link pending
bukit_10q.htm Edgar Link pending
bukit_ex311.htm Edgar Link pending
bukit_ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
bukit-20230930_pre.xml Edgar Link unprocessable
bukit-20230930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
bukit_10q_htm.xml Edgar Link completed
bukit-20230930_cal.xml Edgar Link unprocessable
bukit-20230930_def.xml Edgar Link unprocessable